INTRODUCTION TO SAMPLE-SIZE DETERMINATION AND POWER ANALYSIS FOR CLINICAL-TRIALS

被引:766
作者
LACHIN, JM
机构
来源
CONTROLLED CLINICAL TRIALS | 1981年 / 2卷 / 02期
关键词
D O I
10.1016/0197-2456(81)90001-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:93 / 113
页数:21
相关论文
共 20 条
[1]  
Cochran W.G., 1964, EXPT DESIGNS
[2]  
CUTLER SJ, 1958, J CHRON DIS, V8, P699
[3]   CORRELATION COEFFICIENTS MEASURED ON SAME INDIVIDUALS [J].
DUNN, OJ ;
CLARK, V .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1969, 64 (325) :366-&
[4]  
FLEISS JL, 1973, STATISTICAL METHODS
[5]   IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS [J].
FREIMAN, JA ;
CHALMERS, TC ;
SMITH, H ;
KUEBLER, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) :690-694
[6]   PLANNING SIZE AND DURATION OF A CLINICAL TRIAL STUDYING TIME TO SOME CRITICAL EVENT [J].
GEORGE, SL ;
DESU, MM .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2) :15-24
[7]  
Gross AJ., 1975, SURVIVAL DISTRIBUTIO
[8]   SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY [J].
HALPERIN, M ;
ROGOT, E ;
GURIAN, J ;
EDERER, F .
JOURNAL OF CHRONIC DISEASES, 1968, 21 (01) :13-&
[9]  
JOHNSON NL, 1970, DISTRIBUTIONS STATIS, V2
[10]  
LACHIN J, 1979, GUIDELINES DETECTION, P119